Elafibranor

TargetMol
Product Code: TAR-T4408
Supplier: TargetMol
CodeSizePrice
TAR-T4408-1mL1 mL * 10 mM (in DMSO)£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4408-5mg5mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4408-10mg10mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4408-25mg25mg£181.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4408-50mg50mg£253.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4408-100mg100mg£390.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4408-500mg500mg£831.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Elafibranor is an agonist of the peroxisome proliferator-activated receptor-α (PPAR-α) and peroxisome proliferator-activated receptor-δ (PPAR-δ) with EC50 values of 45 and 175 nM, respectively.
CAS:
923978-27-2
Formula:
C22H24O4S
Molecular Weight:
384.49
Pathway:
Metabolism; DNA Damage/DNA Repair
Purity:
0.9955
SMILES:
CSc1ccc(cc1)C(=O)C=Cc1cc(C)c(OC(C)(C)C(O)=O)c(C)c1
Target:
PPAR

References

Ratziu V,etal.Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-? and -?, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening. Gastroenterology. 2016 May;150(5):1147-1159. Liu ZM,etal.Early investigational drugs targeting PPAR-? for the treatment of metabolic disease.Expert Opin Investig Drugs. 2015 May;24(5):611-21. Hanf R,etal.The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effects.Diab Vasc Dis Res. 2014 Nov;11(6):440-7.